Avenue Therapeutics, Inc. - ATXI

About Gravity Analytica
Recent News
- 04.02.2025 - SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership
- 04.02.2025 - 4 - Statement of changes in beneficial ownership of securities
- 03.31.2025 - 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
- 03.17.2025 - 8-K - Current report
- 03.07.2025 - 8-K - Current report
- 02.14.2025 - SCHEDULE 13G/A -
- 02.14.2025 - SCHEDULE 13G -
- 01.03.2025 - SCHEDULE 13D/A -
- 01.03.2025 - 3 - Initial statement of beneficial ownership of securities
- 12.04.2024 - S-3 - Registration statement for specified transactions by certain issuers
Recent Filings
- 03.31.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
- 03.17.2025 - 8-K Current report
- 03.07.2025 - 8-K Current report
- 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 02.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
- 01.03.2025 - 3 Initial statement of beneficial ownership of securities
- 01.03.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
- 12.04.2024 - S-3 Registration statement under Securities Act of 1933